Treatment TGI (%) T/C TGD (days)
CIGB-552 (1 mg/kg) s.c 60.7 39.3 6.5
CDDP (0.4 mg/kg) i.p 86.7 13.3 5.8
CIGB-552 (1 mg/kg) s.c + CDDP (0.4 mg/Kg) i.p 98.1 1.9 9.5
TGI, tumor growth inhibition; TGD, tumor growth delay; T/C, treated and control animals ratio (‹15 highly effective, ‹50 effective, 15–50 moderate, ›50 no effective); s.c, subcutaneous route; i.p, intraperitoneal route. TGI, tumor growth inhibition; TGD, tumor growth delay; T/C, treated and control animals ratio (‹15 highly effective, ‹50 effective, 15–50 moderate, ›50 no effective); s.c, subcutaneous route; i.p, intraperitoneal route. TGI, tumor growth inhibition; TGD, tumor growth delay; T/C, treated and control animals ratio (‹15 highly effective, ‹50 effective, 15–50 moderate, ›50 no effective); s.c, subcutaneous route; i.p, intraperitoneal route. TGI, tumor growth inhibition; TGD, tumor growth delay; T/C, treated and control animals ratio (‹15 highly effective, ‹50 effective, 15–50 moderate, ›50 no effective); s.c, subcutaneous route; i.p, intraperitoneal route.